- Home
- TURN vs VRCA Comparison
TURN vs VRCA Comparison
Compare TURN & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TURN
- VRCA
- Stock Information
- Founded
- TURN 1981
- VRCA 2013
- Country
- TURN United States
- VRCA United States
- Employees
- TURN 8
- VRCA N/A
- Industry
- TURN Finance/Investors Services
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- TURN Finance
- VRCA Health Care
- Exchange
- TURN Nasdaq
- VRCA Nasdaq
- Market Cap
- TURN 49.6M
- VRCA 58.7M
- IPO Year
- TURN N/A
- VRCA 2018
- Fundamental
- Price
- TURN $4.96
- VRCA $5.00
- Analyst Decision
- TURN
- VRCA Hold
- Analyst Count
- TURN 0
- VRCA 5
- Target Price
- TURN N/A
- VRCA $60.00
- AVG Volume (30 Days)
- TURN 33.1K
- VRCA 36.2K
- Earning Date
- TURN 02-26-2018
- VRCA 11-03-2025
- Dividend Yield
- TURN N/A
- VRCA N/A
- EPS Growth
- TURN N/A
- VRCA N/A
- EPS
- TURN 0.29
- VRCA N/A
- Revenue
- TURN $488,011.00
- VRCA $14,704,000.00
- Revenue This Year
- TURN N/A
- VRCA $264.34
- Revenue Next Year
- TURN N/A
- VRCA $33.95
- P/E Ratio
- TURN $17.34
- VRCA N/A
- Revenue Growth
- TURN 277.43
- VRCA 5.72
- 52 Week Low
- TURN $3.12
- VRCA $3.82
- 52 Week High
- TURN $5.01
- VRCA $20.60
- Technical
- Relative Strength Index (RSI)
- TURN 67.09
- VRCA 38.30
- Support Level
- TURN $4.51
- VRCA $4.87
- Resistance Level
- TURN $4.90
- VRCA $5.20
- Average True Range (ATR)
- TURN 0.17
- VRCA 0.32
- MACD
- TURN -0.01
- VRCA -0.02
- Stochastic Oscillator
- TURN 90.00
- VRCA 19.15
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.